Summary Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company also offers development and production services for finished dosage forms including sterile filling. Siegfried serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Switzerland. Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and... Research Beam Model: Research Beam Product ID: 1995989 250 USD New
Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
 
 

Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile

  • Category : Pharmaceuticals
  • Published On : August   2017
  • Pages : 26
  • Publisher : GlobalData
 
 
 
Summary

Siegfried Holding AG (Siegfried) is a custom manufacturing organization (CMO). The company is active in the primary and secondary production of drugs. It develops and manufactures active pharmaceutical ingredients (APIs) for the research-based pharmaceutical industry and corresponding intermediates and controlled substances. The company also offers development and production services for finished dosage forms including sterile filling. Siegfried serves principally companies operating in pharmaceutical industry. It has production facilities in the USA, Switzerland, Malta, China, Germany and France. The company offers its products in USA Europe and other countries. Siegfried is headquartered in Zofingen, Switzerland.

Siegfried Holding AG (SFZN) - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.
Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deal Details 10
Debt Offering 10
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Acquisition 13
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG - Key Competitors 16
Siegfried Holding AG - Key Employees 17
Siegfried Holding AG - Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Recent Developments 20
Financial Announcements 20
Aug 18, 2016: Siegfried with Jump in Sales 20
Mar 22, 2016: Siegfried with Record Sales in 2015 22
Corporate Communications 24
Mar 09, 2016: Siegfried: Ulla Schmidt and Martin Schmid recommended for nomination to the Board of Directors 24
Legal and Regulatory 25
Jun 27, 2016: Chinese authorities issued operating approval to Siegfried Nantong 25
Appendix 26
Methodology 26
About GlobalData 26
Contact Us 26
Disclaimer 26

List of Tables
Siegfried Holding AG, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Deals By Therapy Area, 2011 to YTD 2017 8
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 9
Siegfried to Raise Additional USD15.4 Million in Public Offering of 2.125% Bond Due 2021 10
Siegfried Raises USD149.6 Million in Public Offering of 2.125 Bond Due 2021 11
Siegfried Holding Raises USD61.33 Million in Bonds Offering 12
Siegfried Acquires Hameln Pharma for USD62 Million 13
Siegfried Acquires Alliance Medical Products For US$58 Million 15
Siegfried Holding AG, Key Competitors 16
Siegfried Holding AG, Key Employees 17
Siegfried Holding AG, Subsidiaries 18
List of Figures
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 2
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 6
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Siegfried Holding AG, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
PURCHASE OPTIONS
 
 
 

How can we help you?

Contact us at the Consulting WP office nearest to you or submit a business inquiry online.


  Contact
 

Subscribe to Our Newsletter